Average activity profiles (left column) and double-plotted actograms (right column) of <i>Marinogammarus marinus</i> (A-B) and <i>Gammarus pulex</i> (C-D) under the LD light regime... حسب Charlotte N. Underwood (5043110)

Age-specific numbers and rates of DALYs (A) and deaths (B) for <i><i>Klebsiella pneumoniae</i></i> associated LRI burden by sex, 2021. DALYs disability-adjusted life years. حسب Juanjuan Li (399633)

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 3 level. حسب P.G.J. ter Horst (21743830)

Univariable and multivariable analyses (age-adjusted), concerning a selection of medicaments p < 0.1 and n ≥ 10. حسب P.G.J. ter Horst (21743830)

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 7 level. حسب P.G.J. ter Horst (21743830)

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning medicament(s) use and Low Semen Quality (LSQ). حسب P.G.J. ter Horst (21743830)

Prevalence of low semen quality including 95% confidence interval (CI) for medication at the ATC 5 level. حسب P.G.J. ter Horst (21743830)

S1 Data - Medication, age and abstinence days associated with low semen quality: A cross-sectional study in more than 7000 men visiting the centre for reproductive medicine حسب P.G.J. ter Horst (21743830)

Univariable and multivariable analyses (age- and abstinence days-adjusted), concerning a selection of medicaments with n ≥ 10 medicament users and p < 0.1 by univariate analysis.... حسب P.G.J. ter Horst (21743830)

A. Proportion of men with Low Semen Quality (LSQ) including 95% confidence interval (CI) versus prevalence, overall and for men on medication(s) (M); B: Point estimates with 95% CI... حسب P.G.J. ter Horst (21743830)

The Vancouver Scar Scale. حسب Na Wang (193263)

S1 Dataset - حسب Na Wang (193263)

Numerical Rating Scale (NRS). حسب Na Wang (193263)

Mammary fistula (n(%)). حسب Na Wang (193263)

Flowchart of included and excluded patients. حسب P.G.J. ter Horst (21743830)

Characteristics of the study group. حسب P.G.J. ter Horst (21743830)

Forest maps affecting lactation outcomes. حسب Na Wang (193263)

Postoperative drainage(ml) (M(IQR)). حسب Na Wang (193263)

Time course of central retinal thickness (CRT) in all eyes. حسب Yasuyuki Sotani (20114144)

"…The mean number of treatments—including anti-VEGF, STTA, MA-PC, and PPV—in the year before surgery was 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, and 0.1 ± 0.3, respectively, with a total of 3.7 ± 1.7 treatments. These treatment frequencies declined significantly after surgery: at 1 year postoperatively, the averages were 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at 2 years, 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at 3 years, 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g003" target="_blank">Fig 3</a>). …"

Annual treatment frequencies in all eyes. حسب Yasuyuki Sotani (20114144)

"…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …"